Gene Details



Il10 and homologs in 4 species are found in 1554 GeneSets:


- Entrez   - Ensembl   - GeneNetwork   - STRING   - Allen Brain Atlas   - MGI   - Comparative Toxicogenomics Database  

Select gene sets below using the check boxes, and then add them to a project using the pull down below. You can also create a project using the pull down. To view a set, click on the GeneSetID:GeneSet Description shown in green below.
GS185131: GO:0044699 single-organism process
GS207306: GO:0080134 regulation of response to stress
GS198398: GO:0050670 regulation of lymphocyte proliferation
GS164444: MP:0005197 abnormal uvea morphology
GS122866: Polysaccharides interacting genes (MeSH:D011134) in CTD
GS170247: MP:0002038 carcinoma
GS170447: MP:0010210 abnormal circulating cytokine level
GS182704: GO:0051172 negative regulation of nitrogen compound metabolic process
GS124545: Amphotericin B interacting genes (MeSH:D000666) in CTD
GS206380: GO:0001763 morphogenesis of a branching structure
GS208257: GO:0016064 immunoglobulin mediated immune response
GS184458: GO:0009892 negative regulation of metabolic process
GS192324: GO:0050727 regulation of inflammatory response
GS122940: Dimethylnitrosamine interacting genes (MeSH:D004128) in CTD
GS191625: GO:0040007 growth
GS188071: GO:0042176 regulation of protein catabolic process
GS205081: GO:0032715 negative regulation of interleukin-6 production
GS168559: MP:0002421 abnormal cell-mediated immunity
GS169830: MP:0005384 cellular phenotype
GS166949: MP:0009308 adenocarcinoma
GS170667: MP:0010080 abnormal hepatocyte physiology
GS191193: GO:0009607 response to biotic stimulus
GS202544: GO:0032655 regulation of interleukin-12 production
GS169029: MP:0005554 decreased circulating creatinine level
GS123199: Tobacco Smoke Pollution interacting genes (MeSH:D014028) in CTD
GS163905: MP:0000493 rectal prolapse
GS182241: GO:0043068 positive regulation of programmed cell death
GS207674: GO:0002697 regulation of immune effector process
GS206098: GO:0002263 cell activation involved in immune response
GS195083: GO:0007267 cell-cell signaling
GS124517: ONO-AE1-329 interacting genes (MeSH:C461399) in CTD
GS163666: MP:0005278 abnormal cholesterol homeostasis
GS201231: GO:0060548 negative regulation of cell death
GS123134: Forskolin interacting genes (MeSH:D005576) in CTD
GS123450: 4-phenylenediamine interacting genes (MeSH:C029728) in CTD
GS206817: GO:0032640 tumor necrosis factor production
GS122521: Nitric Oxide interacting genes (MeSH:D009569) in CTD
GS199041: GO:0045349 interferon-alpha biosynthetic process
GS168334: MP:0002619 abnormal lymphocyte morphology
GS169842: MP:0004392 abnormal CD8-positive T cell physiology
GS187887: GO:0080090 regulation of primary metabolic process
GS136080: juvenile cystic kidney modifier 2 (Jckm2, Published QTL Chr 1)
GS165992: MP:0008469 abnormal protein level
GS191035: GO:0005125 cytokine activity
GS121804: Ro 41-5253 interacting genes (MeSH:C084904) in CTD
GS166858: MP:0000685 abnormal immune system morphology
GS164893: MP:0003075 altered response to CNS ischemic injury
GS165564: MP:0008120 abnormal myeloid dendritic cell number
GS166749: MP:0002221 abnormal lymph organ size
GS163010: MP:0011181 increased hematopoietic cell number
GS126646: Carbon Tetrachloride interacting genes (MeSH:D002251) in CTD
GS206108: GO:2001141 regulation of RNA biosynthetic process
GS207473: GO:0033157 regulation of intracellular protein transport
GS184917: GO:0002252 immune effector process
GS198029: GO:0051651 maintenance of location in cell
GS200210: GO:0002676 regulation of chronic inflammatory response
GS181414: GO:0032880 regulation of protein localization
GS177265: GO:0048731 system development
GS167214: MP:0005319 abnormal enzyme/ coenzyme level
GS207925: GO:0034645 cellular macromolecule biosynthetic process
GS165136: MP:0003009 abnormal cytokine secretion
GS181893: GO:0048522 positive regulation of cellular process
GS165874: MP:0002133 abnormal respiratory system physiology
GS165194: MP:0001533 abnormal skeleton physiology
GS167383: MP:0005328 abnormal circulating creatinine level
GS126466: Quercetin interacting genes (MeSH:D011794) in CTD
GS183543: GO:0051179 localization
GS122239: Cefuroxime interacting genes (MeSH:D002444) in CTD
GS166547: MP:0008662 abnormal interleukin-12 secretion
GS162953: MP:0002020 increased tumor incidence
GS202162: GO:0005126 cytokine receptor binding
GS202527: GO:0032386 regulation of intracellular transport
GS193414: GO:0044249 cellular biosynthetic process
GS123943: Curcumin interacting genes (MeSH:D003474) in CTD
GS187861: GO:0032689 negative regulation of interferon-gamma production
GS124239: Gonadal Steroid Hormones interacting genes (MeSH:D012739) in CTD
GS194599: GO:0002902 regulation of B cell apoptotic process
GS206264: GO:0044116 growth of symbiont involved in interaction with host
GS135642: chronic kidney disease blood pressure locus 1 (Ckdbp1, Published QTL Chr 1)
GS166565: MP:0000693 spleen hyperplasia
GS180114: GO:0044419 interspecies interaction between organisms
GS35289: Whole Brain Gene expression correlates of Prepulse inhibition at 80db in Females & Males BXD
GS202796: GO:0051046 regulation of secretion
GS203970: GO:0046209 nitric oxide metabolic process
GS135622: cholesterol 7 (Chol7, Published QTL Chr 1)
GS205659: GO:0042493 response to drug
GS184456: GO:0009894 regulation of catabolic process
GS197348: GO:0050777 negative regulation of immune response
GS163994: MP:0008248 abnormal mononuclear phagocyte morphology
GS193298: GO:0002861 regulation of inflammatory response to antigenic stimulus
GS125752: 1,6-hexamethylene diisocyanate interacting genes (MeSH:C015262) in CTD
GS193550: GO:0002274 myeloid leukocyte activation
GS125418: adenosine 5'-O-(3-thiotriphosphate) interacting genes (MeSH:C022571) in CTD
GS197754: GO:0042533 tumor necrosis factor biosynthetic process
GS209170: GO:0033619 membrane protein proteolysis
GS123006: Tetanus Toxoid interacting genes (MeSH:D013745) in CTD
GS126023: oxymatrine interacting genes (MeSH:C037573) in CTD
GS167580: MP:0008617 increased circulating interleukin-12 level
GS136382: obesity and body weight QTL 1 (Obwq1, Published QTL Chr 1)
GS206237: GO:0042981 regulation of apoptotic process
GS121412: Mycophenolic Acid interacting genes (MeSH:D009173) in CTD
GS164042: MP:0002018 malignant tumors
GS166409: MP:0002114 abnormal axial skeleton morphology
GS201696: GO:0010941 regulation of cell death
GS206265: GO:0044117 growth of symbiont in host
GS201367: GO:0019538 protein metabolic process
GS182982: GO:0043066 negative regulation of apoptotic process
GS210704: GO:0032635 interleukin-6 production
GS167127: MP:0005280 abnormal fatty acid level
GS195340: GO:0045893 positive regulation of transcription, DNA-dependent
GS122473: Ciprofloxacin interacting genes (MeSH:D002939) in CTD
GS202468: GO:0070887 cellular response to chemical stimulus
GS182703: GO:0051171 regulation of nitrogen compound metabolic process
GS203482: GO:0044093 positive regulation of molecular function
GS186790: GO:0006725 cellular aromatic compound metabolic process
GS163850: MP:0001542 abnormal bone strength
GS169075: MP:0002078 abnormal glucose homeostasis
GS168683: MP:0000598 abnormal liver morphology
GS165738: MP:0008476 increased spleen red pulp amount
GS204150: GO:0009611 response to wounding
GS126828: Glucocorticoids interacting genes (MeSH:D005938) in CTD
GS167896: MP:0009355 increased liver triglyceride level
GS166118: MP:0002109 abnormal limb morphology
GS200341: GO:0051179 localization
GS210464: GO:0060711 labyrinthine layer development
GS189751: GO:0050794 regulation of cellular process
GS164323: MP:0000511 abnormal intestinal mucosa morphology
GS195668: GO:0042221 response to chemical stimulus
GS136668: skin tumor susceptibility 8 (Skts8, Published QTL Chr 1)
GS165171: MP:0008835 abnormal intercellular signaling peptide or protein level
GS189510: GO:0001763 morphogenesis of a branching structure
GS209010: GO:1901575 organic substance catabolic process
GS189140: GO:0030889 negative regulation of B cell proliferation
GS194735: GO:0030163 protein catabolic process
GS200566: GO:0019724 B cell mediated immunity
GS180036: GO:0032501 multicellular organismal process
GS195710: GO:0032268 regulation of cellular protein metabolic process
GS196930: GO:0065007 biological regulation
GS200312: GO:0019219 regulation of nucleobase-containing compound metabolic process
GS177859: GO:0045944 positive regulation of transcription from RNA polymerase II promoter
GS205998: GO:0030885 regulation of myeloid dendritic cell activation
GS210574: GO:0002712 regulation of B cell mediated immunity
GS195660: GO:0061138 morphogenesis of a branching epithelium
GS169303: MP:0008250 abnormal myeloid leukocyte morphology
GS168407: MP:0005465 abnormal T-helper 1 physiology
GS167542: MP:0001790 abnormal immune system physiology
GS203058: GO:0048519 negative regulation of biological process
GS197244: GO:0044237 cellular metabolic process
GS201264: GO:0009890 negative regulation of biosynthetic process
GS188227: GO:0032715 negative regulation of interleukin-6 production
GS163083: MP:0010279 increased gastrointestinal tumor incidence
GS208562: GO:0040008 regulation of growth
GS209284: GO:0010627 regulation of intracellular protein kinase cascade
GS203373: GO:0002683 negative regulation of immune system process
GS125802: Asbestos, Serpentine interacting genes (MeSH:D017632) in CTD
GS165418: MP:0002490 abnormal immunoglobulin level
GS210285: GO:0071887 leukocyte apoptotic process
GS166649: MP:0011504 abnormal limb long bone morphology
GS170779: MP:0000182 increased circulating LDL cholesterol level
GS201262: GO:0009892 negative regulation of metabolic process
GS163412: MP:0004016 decreased bone mass
GS170782: MP:0000181 abnormal circulating LDL cholesterol level
GS178589: GO:0045893 positive regulation of transcription, DNA-dependent
GS122625: beta-Lactams interacting genes (MeSH:D047090) in CTD
GS169037: MP:0010183 abnormal CD4-positive helper T cell morphology
GS170360: MP:0001828 abnormal T cell activation
GS124150: sodium bichromate interacting genes (MeSH:C016104) in CTD
GS124301: N-chlorotaurine interacting genes (MeSH:C043410) in CTD
GS136152: limb length QTL 1 (Lmblgq1, Published QTL Chr 1)
GS123854: Cyclophosphamide interacting genes (MeSH:D003520) in CTD
GS162933: MP:0005636 abnormal mineral homeostasis
GS177990: GO:0030163 protein catabolic process
GS122365: Suramin interacting genes (MeSH:D013498) in CTD
GS169777: MP:0002398 abnormal bone marrow cell morphology/development
GS169748: MP:0008577 increased circulating interferon-gamma level
GS204158: GO:0032800 receptor biosynthetic process
GS199986: GO:0009719 response to endogenous stimulus
GS126780: S-Nitrosoglutathione interacting genes (MeSH:D026422) in CTD
GS122841: beta-Glucans interacting genes (MeSH:D047071) in CTD
GS168342: MP:0008752 abnormal tumor necrosis factor level
GS195457: GO:0060341 regulation of cellular localization
GS169409: MP:0004939 abnormal B cell morphology
GS126432: Dydrogesterone interacting genes (MeSH:D004394) in CTD
GS201848: GO:0048598 embryonic morphogenesis
GS197024: GO:0051045 negative regulation of membrane protein ectodomain proteolysis
GS166994: MP:0008721 abnormal chemokine level
GS166828: MP:0010871 abnormal trabecular bone mass
GS210580: GO:0002718 regulation of cytokine production involved in immune response
GS164443: MP:0005196 abnormal posterior uvea morphology
GS166250: MP:0008247 abnormal mononuclear cell morphology
GS210084: GO:0044144 modulation of growth of symbiont involved in interaction with host
GS126950: zoledronic acid interacting genes (MeSH:C088658) in CTD
GS167587: MP:0009813 abnormal leukotriene level
GS187420: GO:0031644 regulation of neurological system process
GS188506: GO:0010467 gene expression
GS193343: GO:0071887 leukocyte apoptotic process
GS206201: GO:0043124 negative regulation of I-kappaB kinase/NF-kappaB cascade
GS208012: GO:0044464 cell part
GS125511: Vanadium interacting genes (MeSH:D014639) in CTD
GS183422: GO:0043903 regulation of symbiosis, encompassing mutualism through parasitism
GS187113: GO:0005615 extracellular space
GS189324: GO:0048585 negative regulation of response to stimulus
GS201239: GO:0046483 heterocycle metabolic process
GS193929: GO:0042098 T cell proliferation
GS188763: GO:0009888 tissue development
GS192073: GO:1901576 organic substance biosynthetic process
GS188399: GO:0044238 primary metabolic process
GS162983: MP:0002356 abnormal spleen red pulp morphology
GS167056: MP:0004686 decreased length of long bones
GS208060: GO:0010557 positive regulation of macromolecule biosynthetic process
GS167561: MP:0008808 decreased spleen iron level
GS184435: GO:0046483 heterocycle metabolic process
GS122784: Terbutaline interacting genes (MeSH:D013726) in CTD
GS210100: GO:0032945 negative regulation of mononuclear cell proliferation
GS168422: MP:0000716 abnormal immune system cell morphology
GS181032: GO:0001701 in utero embryonic development
GS192090: GO:0019233 sensory perception of pain
GS165320: MP:0008669 increased interleukin-12b secretion
GS122443: Morphine interacting genes (MeSH:D009020) in CTD
GS123554: vinclozolin interacting genes (MeSH:C025643) in CTD
GS166567: MP:0000691 enlarged spleen
GS186214: GO:0048518 positive regulation of biological process
GS196918: GO:0048870 cell motility
GS202556: GO:0043434 response to peptide hormone stimulus
GS162932: MP:0005637 abnormal iron homeostasis
GS166556: MP:0008668 abnormal interleukin-12b secretion
GS205623: GO:0009888 tissue development
GS193564: GO:0043901 negative regulation of multi-organism process
GS184220: GO:0071702 organic substance transport
GS163262: MP:0003763 abnormal thymus physiology
GS163277: MP:0011049 impaired adaptive thermogenesis
GS123718: Ethinyl Estradiol interacting genes (MeSH:D004997) in CTD
GS165415: MP:0002499 chronic inflammation
GS198022: GO:0002703 regulation of leukocyte mediated immunity
GS177310: GO:1901360 organic cyclic compound metabolic process
GS203755: GO:0016265 death
GS163241: MP:0002367 abnormal thymus lobule morphology
GS205053: GO:0006809 nitric oxide biosynthetic process
GS163349: MP:0008555 abnormal interferon secretion
GS167020: MP:0003956 abnormal body size
GS200016: GO:0001817 regulation of cytokine production
GS169535: MP:0005397 hematopoietic system phenotype
GS165789: MP:0005369 muscle phenotype
GS126265: Diazinon interacting genes (MeSH:D003976) in CTD
GS192959: GO:0002237 response to molecule of bacterial origin
GS169833: MP:0005380 embryogenesis phenotype
GS204096: GO:0030183 B cell differentiation
GS127019: 2-Naphthylamine interacting genes (MeSH:D015081) in CTD
GS163071: MP:0000559 abnormal femur morphology
GS191157: GO:0010558 negative regulation of macromolecule biosynthetic process
GS126764: Calcitriol interacting genes (MeSH:D002117) in CTD
GS191151: GO:0010556 regulation of macromolecule biosynthetic process
GS199850: GO:0090317 negative regulation of intracellular protein transport
GS198056: GO:0048568 embryonic organ development
GS170338: MP:0008801 abnormal erythroid progenitor cell morphology
GS209282: GO:0010628 positive regulation of gene expression
GS163667: MP:0008568 abnormal interleukin secretion
GS126206: Nicotine interacting genes (MeSH:D009538) in CTD
GS168027: MP:0000740 impaired smooth muscle contractility
GS169530: MP:0005390 skeleton phenotype
GS123002: phthalic anhydride interacting genes (MeSH:C043103) in CTD
GS123223: Minerals interacting genes (MeSH:D008903) in CTD
GS198948: GO:0006310 DNA recombination
GS200216: GO:0043903 regulation of symbiosis, encompassing mutualism through parasitism
GS199635: GO:0005622 intracellular
GS206934: GO:0051223 regulation of protein transport
GS195206: GO:0002520 immune system development
GS163591: MP:0005015 increased T cell number
GS125044: Acetaldehyde interacting genes (MeSH:D000079) in CTD
GS169227: MP:0001405 impaired coordination
GS208061: GO:0010556 regulation of macromolecule biosynthetic process
GS206406: GO:0010741 negative regulation of intracellular protein kinase cascade
GS189934: GO:0032640 tumor necrosis factor production
GS213076: Genes with suggestive difference in (B6) vs (B6PF1 + PB6F1 + PWD) comparison
GS163077: MP:0010274 increased organ/body region tumor incidence
GS206451: GO:0042089 cytokine biosynthetic process
GS196794: GO:0046907 intracellular transport
GS121552: cobaltiprotoporphyrin interacting genes (MeSH:C007095) in CTD
GS193233: GO:0031329 regulation of cellular catabolic process
GS188477: GO:0032269 negative regulation of cellular protein metabolic process
GS126895: Formaldehyde interacting genes (MeSH:D005557) in CTD
GS167323: MP:0003949 abnormal circulating lipid level
GS121486: Freund's Adjuvant interacting genes (MeSH:D005620) in CTD
GS165244: MP:0010771 integument phenotype
GS123751: Cadmium interacting genes (MeSH:D002104) in CTD
GS125729: SR 144528 interacting genes (MeSH:C110630) in CTD
GS208185: GO:0010035 response to inorganic substance
GS196941: GO:0008150 biological_process
GS198642: GO:0002874 regulation of chronic inflammatory response to antigenic stimulus
GS170368: MP:0000249 abnormal blood vessel physiology
GS183067: GO:0032101 regulation of response to external stimulus
GS127296: 1,5-anhydrofructose interacting genes (MeSH:C048927) in CTD
GS207176: GO:0050865 regulation of cell activation
GS165567: MP:0008271 abnormal bone ossification
GS166520: MP:0000479 abnormal enterocyte morphology
GS204029: GO:0010648 negative regulation of cell communication
GS207271: GO:0042742 defense response to bacterium
GS169860: MP:0008097 increased plasma cell number
GS169908: MP:0001601 abnormal myelopoiesis
GS166150: MP:0001577 anemia
GS182222: GO:0002367 cytokine production involved in immune response
GS187648: GO:0048729 tissue morphogenesis
GS189882: GO:0048545 response to steroid hormone stimulus
GS167021: MP:0003957 abnormal nitric oxide homeostasis
GS166604: MP:0005338 atherosclerotic lesions
GS198019: GO:0002706 regulation of lymphocyte mediated immunity
GS200030: GO:0032868 response to insulin stimulus
GS165134: MP:0008599 increased circulating interleukin-2 level
GS204007: GO:0044700 single organism signaling
GS126171: Capsaicin interacting genes (MeSH:D002211) in CTD
GS196282: GO:0012501 programmed cell death
GS201431: GO:0005515 protein binding
GS194367: GO:0032675 regulation of interleukin-6 production
GS162826: MP:0008539 decreased susceptibility to induced colitis
GS204146: GO:0070230 positive regulation of lymphocyte apoptotic process
GS165615: MP:0002123 abnormal hematopoiesis
GS165214: MP:0001711 abnormal placenta morphology
GS205547: GO:0042130 negative regulation of T cell proliferation
GS206192: GO:0048583 regulation of response to stimulus
GS208559: GO:0040007 growth
GS209411: GO:0048869 cellular developmental process
GS126276: pirinixic acid interacting genes (MeSH:C006253) in CTD
GS190027: GO:0006952 defense response
GS187160: GO:0044707 single-multicellular organism process
GS163314: MP:0005005 abnormal self tolerance
GS177761: GO:0044271 cellular nitrogen compound biosynthetic process
GS194636: GO:0045346 regulation of MHC class II biosynthetic process
GS195273: GO:0070727 cellular macromolecule localization
GS209613: GO:0055085 transmembrane transport
GS124951: Atrazine interacting genes (MeSH:D001280) in CTD
GS164339: MP:0002327 abnormal respiratory function
GS201372: GO:0016444 somatic cell DNA recombination
GS136815: triglyceride QTL 1 (Tglq1, Published QTL Chr 1)
GS181783: GO:0010604 positive regulation of macromolecule metabolic process
GS187128: GO:0051931 regulation of sensory perception
GS210181: GO:0031325 positive regulation of cellular metabolic process
GS198647: GO:0045926 negative regulation of growth
GS127259: glucan phosphate interacting genes (MeSH:C480175) in CTD
GS190051: GO:0051224 negative regulation of protein transport
GS202080: GO:0051252 regulation of RNA metabolic process
GS208051: GO:0002521 leukocyte differentiation
GS170635: MP:0008739 abnormal spleen iron level
GS184781: GO:0009617 response to bacterium
GS208560: GO:0032680 regulation of tumor necrosis factor production
GS164243: MP:0008588 abnormal circulating interleukin level
GS169827: MP:0005387 immune system phenotype
GS163853: MP:0001547 abnormal lipid level
GS170198: MP:0001614 abnormal blood vessel morphology
GS135829: exploratory and excitability QTL 2 (Exq2, Published QTL Chr 1)
GS163620: MP:0002086 abnormal extraembryonic tissue morphology
GS180977: GO:0045184 establishment of protein localization
GS166142: MP:0006237 abnormal choroid vasculature morphology
GS123765: Dobutamine interacting genes (MeSH:D004280) in CTD
GS166187: MP:0000322 increased granulocyte number
GS126498: Dextroamphetamine interacting genes (MeSH:D003913) in CTD
GS210495: GO:0002274 myeloid leukocyte activation
GS122530: helenalin interacting genes (MeSH:C001329) in CTD
GS204021: GO:0044707 single-multicellular organism process
GS205047: GO:0006807 nitrogen compound metabolic process
GS207672: GO:0002695 negative regulation of leukocyte activation
GS191626: GO:0032680 regulation of tumor necrosis factor production
GS167248: MP:0003434 decreased susceptibility to induced choroidal neovascularization
GS184629: GO:0005515 protein binding
GS190178: GO:0051050 positive regulation of transport
GS169603: MP:0001672 abnormal embryogenesis/ development
GS166404: MP:0002113 abnormal skeleton development
GS205458: GO:0050715 positive regulation of cytokine secretion
GS125028: glucuronoxylomannan interacting genes (MeSH:C027478) in CTD
GS163358: MP:0008559 abnormal interferon-gamma secretion
GS129179: spontaneous crescentic glomerulonephritis QTL 2 (Scgq2 Published QTL Chr 1)
GS166978: MP:0005179 decreased circulating cholesterol level
GS194637: GO:0045347 negative regulation of MHC class II biosynthetic process
GS127240: Acetaminophen interacting genes (MeSH:D000082) in CTD
GS167324: MP:0003948 abnormal gas homeostasis
GS126639: Danazol interacting genes (MeSH:D003613) in CTD
GS207863: GO:0009057 macromolecule catabolic process
GS123520: oren gedoku to interacting genes (MeSH:C061676) in CTD
GS197750: GO:0042536 negative regulation of tumor necrosis factor biosynthetic process
GS164667: MP:0005041 abnormal antigen presentation via MHC class II
GS168269: MP:0002434 abnormal T-helper 2 cell morphology
GS164032: MP:0004811 abnormal neuron physiology
GS186488: GO:0048513 organ development
GS170600: MP:0005620 abnormal muscle contractility
GS170601: MP:0005621 abnormal cell physiology
GS185794: GO:0045019 negative regulation of nitric oxide biosynthetic process
GS197665: GO:0051248 negative regulation of protein metabolic process
GS169095: MP:0004924 abnormal behavior
GS206001: GO:0030886 negative regulation of myeloid dendritic cell activation
GS169836: MP:0005388 respiratory system phenotype
GS165983: MP:0008466 enlarged mesenteric lymph nodes
GS187293: GO:0009611 response to wounding
GS166718: MP:0002169 no abnormal phenotype detected
GS205820: GO:0033036 macromolecule localization
GS202798: GO:0051048 negative regulation of secretion
GS196806: GO:0032502 developmental process
GS206618: GO:0050793 regulation of developmental process
GS170301: MP:0005617 increased susceptibility to type IV hypersensitivity reaction
GS126863: resiniferatoxin interacting genes (MeSH:C024353) in CTD
GS168273: MP:0002432 abnormal CD4-positive T cell morphology
GS167994: MP:0002405 respiratory system inflammation
GS170044: MP:0008874 decreased physiological sensitivity to xenobiotic
GS180689: GO:0060670 branching involved in labyrinthine layer morphogenesis
GS166891: MP:0003795 abnormal bone structure
GS186642: GO:0051707 response to other organism
GS164182: MP:0000489 abnormal large intestine morphology
GS201592: GO:0009617 response to bacterium
GS206715: GO:0051674 localization of cell
GS193484: GO:0032615 interleukin-12 production
GS194172: GO:0006915 apoptotic process
GS206299: GO:0032607 interferon-alpha production
GS164022: MP:0008246 abnormal leukocyte morphology
GS194586: GO:0002376 immune system process
GS209009: GO:1901576 organic substance biosynthetic process
GS126106: Ketoprofen interacting genes (MeSH:D007660) in CTD
GS182705: GO:0051173 positive regulation of nitrogen compound metabolic process
GS197644: GO:0006954 inflammatory response
GS208368: GO:0045354 regulation of interferon-alpha biosynthetic process
GS204036: GO:0045321 leukocyte activation
GS210579: GO:0051649 establishment of localization in cell
GS126599: Aluminum Oxide interacting genes (MeSH:D000537) in CTD
GS170104: MP:0003723 abnormal long bone morphology
GS184289: GO:0050707 regulation of cytokine secretion
GS1035: High-priority Candidate Genes for Human Neuropathic Pain
GS185960: GO:0051048 negative regulation of secretion
GS191941: GO:0032720 negative regulation of tumor necrosis factor production
GS126706: Mercury interacting genes (MeSH:D008628) in CTD
GS127109: Antimony Sodium Gluconate interacting genes (MeSH:D000967) in CTD
GS136838: trypansomiasis infection response 3b (Tir3b, Published QTL Chr 1)
GS166598: MP:0005332 abnormal amino acid level
GS182673: GO:0006508 proteolysis
GS164742: MP:0001732 postnatal growth retardation
GS162833: MP:0010124 decreased bone mineral content
GS163356: MP:0008552 abnormal circulating tumor necrosis factor level
GS170414: MP:0008076 abnormal CD4-positive T cell differentiation
GS183756: GO:0010605 negative regulation of macromolecule metabolic process
GS124583: L 663536 interacting genes (MeSH:C060893) in CTD
GS189546: GO:0002440 production of molecular mediator of immune response
GS207071: GO:0051050 positive regulation of transport
GS209714: GO:0034504 protein localization to nucleus
GS207457: GO:0002562 somatic diversification of immune receptors via germline recombination within a single locus
GS206111: GO:0097285 cell-type specific apoptotic process
GS168750: MP:0002191 abnormal artery morphology
GS180476: GO:0070227 lymphocyte apoptotic process
GS205781: GO:0051384 response to glucocorticoid stimulus
GS207175: GO:0050868 negative regulation of T cell activation
GS163902: MP:0000490 abnormal crypts of Lieberkuhn morphology
GS167098: MP:0001819 abnormal immune cell physiology
GS177356: GO:0003674 molecular_function
GS207940: GO:0005125 cytokine activity
GS191722: GO:0008285 negative regulation of cell proliferation
GS177894: GO:0045346 regulation of MHC class II biosynthetic process
GS177717: GO:0051239 regulation of multicellular organismal process
GS201900: GO:0042991 transcription factor import into nucleus
GS167708: MP:0002412 increased susceptibility to bacterial infection
GS196837: GO:0042110 T cell activation
GS194647: GO:0071495 cellular response to endogenous stimulus
GS188410: GO:0032774 RNA biosynthetic process
GS191727: GO:0008283 cell proliferation
GS164446: MP:0005195 abnormal posterior eye segment morphology
GS202005: GO:0006605 protein targeting
GS201261: GO:0009895 negative regulation of catabolic process
GS210095: GO:0032943 mononuclear cell proliferation
GS189939: GO:0032649 regulation of interferon-gamma production
GS203072: GO:0090304 nucleic acid metabolic process
GS125927: roquinimex interacting genes (MeSH:C045282) in CTD
GS189580: GO:0042089 cytokine biosynthetic process
GS207097: GO:0008083 growth factor activity
GS123947: N-(4-O-glycerol-3-methoxybenzyl)nonivamide interacting genes (MeSH:C080418) in CTD
GS164046: MP:0001968 abnormal touch/ nociception
GS183329: GO:0070851 growth factor receptor binding
GS166070: MP:0008873 increased physiological sensitivity to xenobiotic
GS187193: GO:0044057 regulation of system process
GS196715: GO:0042348 NF-kappaB import into nucleus
GS184382: GO:0042107 cytokine metabolic process
GS182242: GO:0045348 positive regulation of MHC class II biosynthetic process
GS169531: MP:0005391 vision/eye phenotype
GS167545: MP:0001793 altered susceptibility to infection
GS190771: GO:0002697 regulation of immune effector process
GS166889: MP:0003797 abnormal compact bone morphology
GS168275: MP:0002439 abnormal plasma cell morphology
GS168848: MP:0002452 abnormal antigen presenting cell physiology
GS162841: MP:0009481 cecum inflammation
GS135872: femur geometry 1 (Fmgty1, Published QTL Chr 1)
GS199468: GO:0006508 proteolysis
GS168705: MP:0008671 abnormal interleukin-13 secretion
GS126291: Dactinomycin interacting genes (MeSH:D003609) in CTD
GS165809: MP:0002864 abnormal ocular fundus morphology
GS166972: MP:0005178 increased circulating cholesterol level
GS182981: GO:0043067 regulation of programmed cell death
GS185961: GO:0051049 regulation of transport
GS199113: GO:0015031 protein transport
GS205758: GO:0016477 cell migration
GS167040: MP:0003887 increased hepatocyte apoptosis
GS193237: GO:0031325 positive regulation of cellular metabolic process
GS195214: GO:0009987 cellular process
GS207177: GO:0050864 regulation of B cell activation
GS210430: GO:0032615 interleukin-12 production
GS163934: MP:0001764 abnormal homeostasis
GS194475: GO:0046823 negative regulation of nucleocytoplasmic transport
GS200648: GO:0044260 cellular macromolecule metabolic process
GS165525: MP:0010768 mortality/aging
GS193639: GO:0051641 cellular localization
GS126349: Peptidoglycan interacting genes (MeSH:D010457) in CTD
GS203318: GO:0042035 regulation of cytokine biosynthetic process
GS169025: MP:0001657 abnormal induced morbidity/mortality
GS121615: U 75302 interacting genes (MeSH:C062137) in CTD
GS188478: GO:0051090 regulation of sequence-specific DNA binding transcription factor activity
GS199262: GO:0032695 negative regulation of interleukin-12 production
GS124173: R 848 interacting genes (MeSH:C402365) in CTD
GS206814: GO:0032647 regulation of interferon-alpha production
GS203642: GO:0006725 cellular aromatic compound metabolic process
GS209385: GO:0044403 symbiosis, encompassing mutualism through parasitism
GS170151: MP:0001716 abnormal placenta labyrinth morphology
GS186472: GO:0042036 negative regulation of cytokine biosynthetic process
GS190050: GO:0051223 regulation of protein transport
GS164770: MP:0009250 abnormal appendicular skeleton morphology
GS201025: GO:0071702 organic substance transport
GS84106: alcohol preference on Chr1 (Published QTL, Chr 1)
GS122250: Hexachlorobenzene interacting genes (MeSH:D006581) in CTD
GS207923: GO:0034641 cellular nitrogen compound metabolic process
GS169335: MP:0005546 choroidal neovascularization
GS168166: MP:0009345 abnormal trabecular bone thickness
GS204720: GO:0032689 negative regulation of interferon-gamma production
GS182990: GO:0043069 negative regulation of programmed cell death
GS194040: GO:1901360 organic cyclic compound metabolic process
GS207069: GO:0051052 regulation of DNA metabolic process
GS136607: splenomegaly-NZB x NZW 1 (Sbw1, Published QTL Chr 1)
GS193009: GO:0042127 regulation of cell proliferation
GS135910: G protein deficiency-induced colitis 2 (Gpdc2, Published QTL Chr 1)
GS163496: MP:0003303 peritoneal inflammation
GS189133: GO:0030885 regulation of myeloid dendritic cell activation
GS201899: GO:0042990 regulation of transcription factor import into nucleus
GS164782: MP:0009543 abnormal thymus corticomedullary boundary morphology
GS167629: MP:0005466 abnormal T-helper 2 physiology
GS190067: GO:0018130 heterocycle biosynthetic process
GS162837: MP:0010122 abnormal bone mineral content
GS186530: GO:0002683 negative regulation of immune system process
GS197948: GO:0002285 lymphocyte activation involved in immune response
GS164299: MP:0005042 abnormal level of surface class II molecules
GS205266: GO:0032774 RNA biosynthetic process
GS195977: GO:0007154 cell communication
GS206418: GO:0002443 leukocyte mediated immunity
GS193923: GO:0042092 type 2 immune response
GS200855: GO:0002875 negative regulation of chronic inflammatory response to antigenic stimulus
GS185013: GO:0002739 regulation of cytokine secretion involved in immune response
GS194905: GO:0008219 cell death
GS194267: GO:0043170 macromolecule metabolic process
GS180452: GO:0044237 cellular metabolic process
GS183630: GO:0002682 regulation of immune system process
GS203827: GO:0051169 nuclear transport
GS164694: MP:0005048 thrombosis
GS206953: GO:0018130 heterocycle biosynthetic process
GS203057: GO:0048518 positive regulation of biological process
GS124457: Mustard Gas interacting genes (MeSH:D009151) in CTD
GS208787: GO:0034613 cellular protein localization
GS200275: GO:0014070 response to organic cyclic compound
GS194499: GO:0044271 cellular nitrogen compound biosynthetic process
GS122242: Ceftazidime interacting genes (MeSH:D002442) in CTD
GS180164: GO:0008150 biological_process
GS163540: MP:0011396 abnormal sleep behavior
GS162899: MP:0003982 increased cholesterol level
GS177531: GO:0043170 macromolecule metabolic process
GS170742: MP:0005023 abnormal wound healing
GS165437: MP:0000438 abnormal cranium morphology
GS163903: MP:0000491 crypts of Lieberkuhn abscesses
GS164952: MP:0001501 abnormal sleep pattern
GS205255: GO:0044238 primary metabolic process
GS207293: GO:0032879 regulation of localization
GS124286: Benzene interacting genes (MeSH:D001554) in CTD
GS177214: GO:0006366 transcription from RNA polymerase II promoter
GS169917: MP:0010155 abnormal intestine physiology
GS207174: GO:0050869 negative regulation of B cell activation
GS186562: GO:0009653 anatomical structure morphogenesis
GS123048: Tretinoin interacting genes (MeSH:D014212) in CTD
GS207858: GO:0009059 macromolecule biosynthetic process
GS208903: GO:0071219 cellular response to molecule of bacterial origin
GS121802: Epinephrine interacting genes (MeSH:D004837) in CTD
GS122892: 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC interacting genes (MeSH:C432747) in CTD
GS192321: GO:0050728 negative regulation of inflammatory response
GS123676: Methylene Chloride interacting genes (MeSH:D008752) in CTD
GS165417: MP:0002493 increased IgG level
GS190954: GO:0009056 catabolic process
GS166472: MP:0004991 decreased bone strength
GS200602: GO:0044267 cellular protein metabolic process
GS163568: MP:0002551 abnormal blood coagulation
GS209953: GO:0042129 regulation of T cell proliferation
GS204929: GO:0042176 regulation of protein catabolic process
GS187616: GO:0070663 regulation of leukocyte proliferation
GS124724: Thalidomide interacting genes (MeSH:D013792) in CTD
GS198204: GO:0032880 regulation of protein localization
GS202169: GO:0045190 isotype switching
GS208365: GO:0045355 negative regulation of interferon-alpha biosynthetic process
GS193575: GO:0045428 regulation of nitric oxide biosynthetic process
GS183514: GO:0019219 regulation of nucleobase-containing compound metabolic process
GS163681: MP:0008566 increased interferon-gamma secretion
GS183848: GO:0044260 cellular macromolecule metabolic process
GS186757: GO:0034654 nucleobase-containing compound biosynthetic process
GS190283: GO:0050866 negative regulation of cell activation
GS122909: Clonidine interacting genes (MeSH:D003000) in CTD
GS123320: Interferon-alpha interacting genes (MeSH:D016898) in CTD
GS166825: MP:0000462 abnormal digestive system morphology
GS169304: MP:0008251 abnormal phagocyte morphology
GS178904: GO:0061138 morphogenesis of a branching epithelium
GS180878: GO:0051246 regulation of protein metabolic process
GS126579: Biliverdine interacting genes (MeSH:D001664) in CTD
GS166412: MP:0002118 abnormal lipid homeostasis
GS204261: GO:0000018 regulation of DNA recombination
GS209025: GO:0019233 sensory perception of pain
GS124648: Lipopolysaccharides interacting genes (MeSH:D008070) in CTD
GS198685: GO:0048522 positive regulation of cellular process
GS166120: MP:0002106 abnormal muscle physiology
GS170086: MP:0000703 abnormal thymus morphology
GS201949: GO:0044699 single-organism process
GS194734: GO:0030162 regulation of proteolysis
GS209256: GO:0050728 negative regulation of inflammatory response
GS190397: GO:0032879 regulation of localization
GS170089: MP:0000706 small thymus
GS208954: GO:0006139 nucleobase-containing compound metabolic process
GS200015: GO:0001816 cytokine production
GS122358: Diazoxide interacting genes (MeSH:D003981) in CTD
GS187111: GO:0046209 nitric oxide metabolic process
GS197488: GO:0060670 branching involved in labyrinthine layer morphogenesis
GS165739: MP:0008477 decreased spleen red pulp amount
GS189244: GO:0097285 cell-type specific apoptotic process
GS181854: GO:0045926 negative regulation of growth
GS188195: GO:0006809 nitric oxide biosynthetic process
GS168549: MP:0000477 abnormal intestine morphology
GS169840: MP:0003711 pathological neovascularization
GS190177: GO:0051051 negative regulation of transport
GS190769: GO:0002695 negative regulation of leukocyte activation
GS124919: Butylated Hydroxytoluene interacting genes (MeSH:D002084) in CTD
GS206935: GO:0051224 negative regulation of protein transport
GS163923: MP:0002896 abnormal bone mineralization
GS190950: GO:0009059 macromolecule biosynthetic process
GS181568: GO:0006357 regulation of transcription from RNA polymerase II promoter
GS199020: GO:0002366 leukocyte activation involved in immune response
GS123883: Methylnitrosourea interacting genes (MeSH:D008770) in CTD
GS163353: MP:0008551 abnormal circulating interferon-gamma level
GS163295: MP:0000219 increased neutrophil cell number
GS178461: GO:0009987 cellular process
GS122587: Galactosamine interacting genes (MeSH:D005688) in CTD
GS166380: MP:0008872 abnormal physiological response to xenobiotic
GS165620: MP:0008125 abnormal dendritic cell number
GS184284: GO:0050708 regulation of protein secretion
GS204284: GO:0031644 regulation of neurological system process
GS177856: GO:0002902 regulation of B cell apoptotic process
GS207182: GO:0050863 regulation of T cell activation
GS168849: MP:0002453 abnormal B lymphocyte antigen presentation
GS191436: GO:0005141 interleukin-10 receptor binding
GS210507: GO:0006950 response to stress
GS124185: Plant Extracts interacting genes (MeSH:D010936) in CTD
GS167941: MP:0001970 abnormal pain threshold
GS199467: GO:0006509 membrane protein ectodomain proteolysis
GS135489: bone response to mechanical loading 9 (Brml9, Published QTL Chr 1)
GS162984: MP:0001800 abnormal humoral immune response
GS169973: MP:0002006 tumorigenesis
GS192770: GO:0050663 cytokine secretion
GS201373: GO:0016447 somatic recombination of immunoglobulin gene segments
GS201728: GO:0002250 adaptive immune response
GS188072: GO:0042177 negative regulation of protein catabolic process
GS181892: GO:0048523 negative regulation of cellular process
GS193268: GO:0005575 cellular_component
GS123865: catechol interacting genes (MeSH:C034221) in CTD
GS188190: GO:0006807 nitrogen compound metabolic process
GS135800: ethanol induced loss of righting response 1 (Elorr1, Published QTL Chr 1)
GS170705: MP:0008092 abnormal T-helper 2 cell differentiation
GS164162: MP:0008704 abnormal interleukin-6 secretion
GS204317: GO:0009725 response to hormone stimulus
GS193151: GO:0032940 secretion by cell
GS199019: GO:0002367 cytokine production involved in immune response
GS200125: GO:0070851 growth factor receptor binding
GS207797: GO:0030154 cell differentiation
GS165656: MP:0003025 increased vasoconstriction
GS190376: GO:0042742 defense response to bacterium
GS207581: GO:0007275 multicellular organismal development
GS184219: GO:0071706 tumor necrosis factor superfamily cytokine production
GS169589: MP:0008713 abnormal cytokine level
GS163271: MP:0006042 increased apoptosis
GS199062: GO:0045351 type I interferon biosynthetic process
GS164113: MP:0002534 abnormal type IV hypersensitivity reaction
GS205002: GO:0048856 anatomical structure development
GS210240: GO:0002861 regulation of inflammatory response to antigenic stimulus
GS125792: Ethanol interacting genes (MeSH:D000431) in CTD
GS135921: growth traits 1 (Gwth1, Published QTL Chr 1)
GS163852: MP:0001544 abnormal cardiovascular system physiology
GS165131: MP:0008596 increased circulating interleukin-6 level
GS202188: GO:0044248 cellular catabolic process
GS163263: MP:0003762 abnormal immune organ physiology
GS184457: GO:0009895 negative regulation of catabolic process
GS166746: MP:0002224 abnormal spleen size
GS201869: GO:0008104 protein localization
GS123595: Progesterone interacting genes (MeSH:D011374) in CTD
GS193518: GO:0060711 labyrinthine layer development
GS193757: GO:0032635 interleukin-6 production
GS201730: GO:0002252 immune effector process
GS207857: GO:0009058 biosynthetic process
GS170358: MP:0001823 thymus hypoplasia
GS163529: MP:0002957 intestinal adenocarcinoma
GS201142: GO:0002200 somatic diversification of immune receptors
GS164101: MP:0003043 hypoalgesia
GS205165: GO:0010243 response to organic nitrogen
GS165657: MP:0003026 decreased vasoconstriction
GS165528: MP:0005379 endocrine/exocrine gland phenotype
GS170655: MP:0001835 abnormal antigen presentation
GS163956: MP:0011180 abnormal hematopoietic cell number
GS167404: MP:0004189 abnormal alveolar process morphology
GS169835: MP:0005389 reproductive system phenotype
GS193140: GO:0044144 modulation of growth of symbiont involved in interaction with host
GS135553: CD8 memory T cell subset 2 (Cd8mts2, Published QTL Chr 1)
GS125829: CGP 57380 interacting genes (MeSH:C466997) in CTD
GS201023: GO:0071704 organic substance metabolic process
GS166706: MP:0002166 altered tumor susceptibility
GS188594: GO:0050710 negative regulation of cytokine secretion
GS194385: GO:0043627 response to estrogen stimulus
GS124165: Hydrogen Peroxide interacting genes (MeSH:D006861) in CTD
GS126989: Hydralazine interacting genes (MeSH:D006830) in CTD
GS206932: GO:0051220 cytoplasmic sequestering of protein
GS201132: GO:0010646 regulation of cell communication
GS184566: GO:0019538 protein metabolic process
GS121272: methyldithiocarbamate interacting genes (MeSH:C008435) in CTD
GS202797: GO:0051047 positive regulation of secretion
GS124881: N-bromotaurine interacting genes (MeSH:C052954) in CTD
GS164598: MP:0002330 abnormal bronchial provocation
GS125650: Pentoxifylline interacting genes (MeSH:D010431) in CTD
GS201191: GO:0042100 B cell proliferation
GS202511: GO:0071391 cellular response to estrogen stimulus
GS124078: methyl isocyanate interacting genes (MeSH:C008461) in CTD
GS179517: GO:0012501 programmed cell death
GS167997: MP:0002406 increased susceptibility to infection
GS169291: MP:0005094 abnormal T cell proliferation
GS186227: GO:0090304 nucleic acid metabolic process
GS201189: GO:0042107 cytokine metabolic process
GS167991: MP:0002401 abnormal lymphopoiesis
GS204612: GO:0019222 regulation of metabolic process
GS163106: MP:0008548 abnormal circulating interferon level
GS210168: GO:0030098 lymphocyte differentiation
GS170416: MP:0008074 increased CD4-positive T cell number
GS166536: MP:0004504 decreased incidence of UV-induced tumors
GS208879: GO:0032720 negative regulation of tumor necrosis factor production
GS127139: Indomethacin interacting genes (MeSH:D007213) in CTD
GS186471: GO:0042035 regulation of cytokine biosynthetic process
GS185054: GO:0008104 protein localization
GS169695: MP:0004946 abnormal regulatory T cell physiology
GS184285: GO:0050709 negative regulation of protein secretion
GS123171: hydroxyhydroquinone interacting genes (MeSH:C013038) in CTD
GS163857: MP:0005065 abnormal neutrophil morphology
GS209072: GO:0045861 negative regulation of proteolysis
GS181267: GO:0048568 embryonic organ development
GS165421: MP:0002497 increased IgE level
GS169293: MP:0005098 abnormal choroid morphology
GS177862: GO:0001775 cell activation
GS164554: MP:0004876 decreased mean systemic arterial blood pressure
GS210508: GO:0043901 negative regulation of multi-organism process
GS204819: GO:0002819 regulation of adaptive immune response
GS200844: GO:0031347 regulation of defense response
GS163820: MP:0002875 decreased erythrocyte cell number
GS167025: MP:0003953 abnormal hormone level
GS164593: MP:0002335 decreased airway responsiveness
GS164133: MP:0005076 abnormal cell differentiation
GS170748: MP:0005025 abnormal response to infection
GS121893: Vitamin E interacting genes (MeSH:D014810) in CTD
GS210099: GO:0032944 regulation of mononuclear cell proliferation
GS168563: MP:0002425 altered susceptibility to autoimmune disorder
GS209225: GO:0007600 sensory perception
GS169133: MP:0002442 abnormal leukocyte physiology
GS206300: GO:0032606 type I interferon production
GS183425: GO:0043900 regulation of multi-organism process
GS203607: GO:0034654 nucleobase-containing compound biosynthetic process
GS185033: GO:0048598 embryonic morphogenesis
GS192074: GO:1901575 organic substance catabolic process
GS205333: GO:0032269 negative regulation of cellular protein metabolic process
GS123070: trimellitic anhydride interacting genes (MeSH:C015559) in CTD
GS178155: GO:0008219 cell death
GS189112: GO:0070201 regulation of establishment of protein localization
GS203494: GO:0051704 multi-organism process
GS189374: GO:0042981 regulation of apoptotic process
GS122319: 2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine interacting genes (MeSH:C069172) in CTD
GS168710: MP:0001648 abnormal apoptosis
GS183216: GO:0001816 cytokine production
GS164596: MP:0002332 abnormal exercise endurance
GS169422: MP:0006173 abnormal myeloid dendritic cell morphology
GS196790: GO:0046903 secretion
GS185585: GO:0044710 single-organism metabolic process
GS208362: GO:0005141 interleukin-10 receptor binding
GS168573: MP:0006060 increased cerebral infarction size
GS187708: GO:0009893 positive regulation of metabolic process
GS126878: Toluene 2,4-Diisocyanate interacting genes (MeSH:D014051) in CTD
GS121419: Terfenadine interacting genes (MeSH:D016593) in CTD
GS193632: GO:0051649 establishment of localization in cell
GS198786: GO:0002544 chronic inflammatory response
GS122222: araldite interacting genes (MeSH:C005752) in CTD
GS136332: non-insulin-dependent diabetes mellitus 6 (Nidd6, Published QTL Chr 1)
GS121731: Diclofenac interacting genes (MeSH:D004008) in CTD
GS197349: GO:0050776 regulation of immune response
GS195712: GO:0060669 embryonic placenta morphogenesis
GS136370: obesity QTL 17 (Obq17, Published QTL Chr 1)
GS203046: GO:0060326 cell chemotaxis
GS189398: GO:0044110 growth involved in symbiotic interaction
GS184709: GO:0002439 chronic inflammatory response to antigenic stimulus
GS206354: GO:0023057 negative regulation of signaling
GS122027: hydroquinone interacting genes (MeSH:C031927) in CTD
GS194588: GO:0002374 cytokine secretion involved in immune response
GS163355: MP:0008553 increased circulating tumor necrosis factor level
GS201092: GO:0050708 regulation of protein secretion
GS164040: MP:0003856 abnormal hindlimb stylopod morphology
GS204479: GO:0070663 regulation of leukocyte proliferation
GS184883: GO:0010942 positive regulation of cell death
GS167222: MP:0005311 abnormal circulating amino acid level
GS198572: GO:0010604 positive regulation of macromolecule metabolic process
GS201924: GO:0044126 regulation of growth of symbiont in host
GS184317: GO:0009790 embryo development
GS167077: MP:0008082 increased single-positive T cell number
GS182672: GO:0006509 membrane protein ectodomain proteolysis
GS203383: GO:0009306 protein secretion
GS199040: GO:0045348 positive regulation of MHC class II biosynthetic process
GS164183: MP:0000488 abnormal intestinal epithelium morphology
GS207070: GO:0051051 negative regulation of transport
GS170643: MP:0004752 decreased length of allograft survival
GS169828: MP:0005386 behavior/neurological phenotype
GS199498: GO:0051170 nuclear import
GS194632: GO:0045342 MHC class II biosynthetic process
GS164669: MP:0010292 increased alimentary system tumor incidence
GS136837: trypansomiasis infection response 3a (Tir3a, Published QTL Chr 1)
GS167626: MP:0005463 abnormal CD4-positive T cell physiology
GS202415: GO:0044710 single-organism metabolic process
GS125893: Tetradecanoylphorbol Acetate interacting genes (MeSH:D013755) in CTD
GS206544: GO:2000112 regulation of cellular macromolecule biosynthetic process
GS169832: MP:0005381 digestive/alimentary phenotype
GS123113: monocyte locomotion inhibitory factor interacting genes (MeSH:C430647) in CTD
GS127334: methylene bis(4-cyclohexylisocyanate) interacting genes (MeSH:C013606) in CTD
GS170411: MP:0008073 abnormal CD4-positive T cell number
GS122916: Clenbuterol interacting genes (MeSH:D002976) in CTD
GS198684: GO:0048523 negative regulation of cellular process
GS165474: MP:0002723 abnormal immune serum protein physiology
GS167627: MP:0005460 abnormal leukopoiesis
GS210177: GO:0031329 regulation of cellular catabolic process
GS197669: GO:0051246 regulation of protein metabolic process
GS210586: GO:0051641 cellular localization
GS185192: GO:0031348 negative regulation of defense response
GS199501: GO:0051173 positive regulation of nitrogen compound metabolic process
GS167656: MP:0001943 abnormal respiration
GS185489: GO:0046651 lymphocyte proliferation
GS200787: GO:0002637 regulation of immunoglobulin production
GS184318: GO:0009792 embryo development ending in birth or egg hatching
GS208906: GO:0071216 cellular response to biotic stimulus
GS122526: phenylmethylpyrazolone interacting genes (MeSH:C005435) in CTD
GS190955: GO:0009057 macromolecule catabolic process
GS206329: GO:0060255 regulation of macromolecule metabolic process
GS165467: MP:0002724 enhanced wound healing
GS204054: GO:0044057 regulation of system process
GS126486: 2,4,5,2',4',5'-hexachlorobiphenyl interacting genes (MeSH:C014024) in CTD
GS165141: MP:0008666 increased interleukin-12a secretion
GS124335: Copper interacting genes (MeSH:D003300) in CTD
GS170759: MP:0009625 abnormal abdominal lymph node morphology